These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3180307)

  • 21. Susceptibility testing accuracy of a CTX-M-type extended-spectrum beta-lactamase organism-producing population of Enterobacteriaceae: intermethod analysis for 9 beta-lactams.
    Pottumarthy S; Yu Y; Sader HS; Jones RN; Chen M
    Diagn Microbiol Infect Dis; 2005 Oct; 53(2):131-41. PubMed ID: 15939566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The in-vitro activity of cefotetan against Serratia spp. and Enterobacter spp. in comparison with other cephalosporins.
    Campello C; Stradoni R; Majori L
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():87-93. PubMed ID: 6573328
    [No Abstract]   [Full Text] [Related]  

  • 23. Cefotetan: in-vitro antibacterial activity and susceptibility to beta-lactamases.
    Phillips I; King A; Shannon K; Warren C
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():1-9. PubMed ID: 6601650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.
    Ayers LW; Jones RN; Barry AL; Thornsberry C; Fuchs PC; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1982 Nov; 22(5):859-77. PubMed ID: 6983862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro interactions between cefotetan and aminoglycosides on Klebsiella, Enterobacter and Serratia species.
    Debbia E; Stefani S; Nicoletti G; Schito GC
    Chemioterapia; 1987 Jun; 6(2 Suppl):94-5. PubMed ID: 3509543
    [No Abstract]   [Full Text] [Related]  

  • 26. Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases.
    Bedenic B; Vranes J; Suto S; Zagar Z
    Int J Antimicrob Agents; 2005 Jun; 25(6):479-87. PubMed ID: 15894465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of Beta-lactamase resistance in enterobacteria].
    Koren J; Vaculíková A
    Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):103-7. PubMed ID: 17051471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence and prevalence of beta-lactamase-producing Klebsiella pneumoniae resistant to cephems in Japan.
    Muratani T; Kobayashi T; Matsumoto T
    Int J Antimicrob Agents; 2006 Jun; 27(6):491-9. PubMed ID: 16701983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of the presence of different broad-spectrum beta-lactamases among clinical isolates of Enterobacteriacae.
    Nagy E; Pragai Z; Kóczián Z; Hajdú E; Fodor E
    Acta Microbiol Immunol Hung; 1998; 45(3-4):433-46. PubMed ID: 9873949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility of clinical isolates of Enterobacteriaceae producing complex beta-lactamase patterns including extended-spectrum enzymes.
    Segatore B; Setacci D; Perilli M; Franchino L; Franceschini N; Agnifili A; Rossolini GM; Amicosante G
    Int J Antimicrob Agents; 2004 May; 23(5):480-6. PubMed ID: 15120727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases.
    Raimondi A; Mattina R; Cocuzza CE
    Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of six beta-lactam antibiotics against non-beta-lactamase producing and producing enterobacteria and antibiotic resistance transfer.
    Scioli C; Esposito S; Martinelli R
    Boll Ist Sieroter Milan; 1984 Sep; 63(4):338-47. PubMed ID: 6335045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative in vitro activity and the inoculum effect of ertapenem against Enterobacteriaceae resistant to extended-spectrum cephalosporins.
    Betriu C; Salso S; Sánchez A; Culebras E; Gómez M; Rodríguez-Avial I; Picazo JJ
    Int J Antimicrob Agents; 2006 Jul; 28(1):1-5. PubMed ID: 16769202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative susceptibilities of organisms isolated in Sicily to cefotetan and other antibiotics.
    Russo G; Gismondo MR; Toscano MA; Speciale AM; Nicoletti G
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():79-85. PubMed ID: 6573327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of cefotetan and the metallo-beta-lactamases produced in Aeromonas spp. and in vitro activity.
    Quiroga MI; Franceschini N; Rossolini GM; Gutkind G; Bonfiglio G; Franchino L; Amicosante G
    Chemotherapy; 2000; 46(3):177-83. PubMed ID: 10765032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cefotetan: antimicrobial activity in-vitro compared with that of cefotaxime.
    Dette GA; Knothe H; Henckel S
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():11-7. PubMed ID: 6302064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of bacterial pathogens to cefotetan judged by MIC and disc tests.
    Grimm H
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():37-43. PubMed ID: 6573324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Determination of the MIC of cefotetan against freshly isolated gram-negative bacilli].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Sato K
    Jpn J Antibiot; 1989 Nov; 42(11):2363-76. PubMed ID: 2621779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of cefotetan, a new cephamycin derivative, compared with that of other beta-lactam compounds.
    Wise R; Andrews JM; Hancox J
    Antimicrob Agents Chemother; 1982 Mar; 21(3):486-91. PubMed ID: 6954875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.